HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor

NEW YORK and DALLAS, Feb. 26 /PRNewswire/ -- HealthpointCapital, LLC. ("HealthpointCapital") announced today that it has appointed Dr. Stephen H. Hochschuler as Clinical Advisor to the Firm. HealthpointCapital is a values- driven, research-based private equity firm exclusively focused on orthopedic and dental device companies. Dr. Hochschuler is the co-founder of the Texas Back Institute, Chairman of Texas Back Institute Holdings and Chairman of the Board, a founding member and former President of the Spine Arthroplasty Society and a board certified orthopedic surgeon.

"We are very pleased that Dr. Hochschuler is joining us as Clinical Advisor," stated Mortimer Berkowitz III, President of HealthpointCapital. "Investing in companies that improve patient care is central to HealthpointCapital investment thesis which means we are continually deepening our scientific knowledge and relationships in order to build companies that offer the most innovative products and best clinical outcomes. Dr. Hochschuler's unparalleled understanding of medical science and advanced technologies will allow us to better deliver to the marketplace and create value for our investors."

Dr. Stephen H. Hochschuler stated, "I am pleased to be working more closely with HealthpointCapital. The firm's research and investment teams have demonstrated their commitment to developing strategies and organizations that are responsive surgeons' needs through innovative product development. I am confident that this partnership will lead to important advancements in the orthopedic device industry."

For More Information:
Lauren Uzdienski
HealthpointCapital, LLC
212.935.7780
www.healthpointcapital.com

About HealthpointCapital

HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HealthpointCapital has $650 million of institutional capital under management. The firm believes it is the only of its kind to focus exclusively on late stage opportunities in the $30 billion worldwide orthopedic and dental device industry. The firm's professionals have a cumulative 85 years of experience in healthcare investing and technology. The firm also publishes extensively on musculoskeletal technologies and industry activities on its dedicated research site at www.healthpointcapital.com

First Call Analyst:
FCMN Contact:

Source: HealthpointCapital, LLC.

CONTACT: Lauren Uzdienski, HealthpointCapital, LLC, +1-212-935-7780

Web site: http://www.healthpointcapital.com/

2008-02-26 17:36:34 0298905 PRNEWSWIRE